ALG11 Gene Congenital Disorder of Glycosylation Type Ip Genetic Test
Test Details
ALG11 Gene Congenital disorder of glycosylation, type Ip is a rare genetic disorder that affects the process of adding sugar molecules to proteins and lipids in the body. This disorder is caused by mutations in the ALG11 gene, which is responsible for encoding an enzyme involved in the glycosylation process.
NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of genetic variations, including mutations, in a more efficient and comprehensive manner compared to traditional sequencing methods.
The ALG11 gene NGS genetic test specifically focuses on sequencing the ALG11 gene to identify any mutations or variations that may be causing the Congenital disorder of glycosylation, type Ip. This test can help diagnose individuals with this disorder, provide information about disease progression and prognosis, and aid in genetic counseling and family planning.
It is important to consult with a healthcare professional or genetic counselor to understand the specific implications and limitations of this genetic test, as well as to discuss the potential benefits and risks of undergoing such testing.
Test Name: ALG11 Gene Congenital disorder of glycosylation type Ip Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for ALG11 Gene Congenital disorder of glycosylation, type Ip NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with Congenital disorder of glycosylation, type Ip
Test Name | ALG11 Gene Congenital disorder of glycosylation type Ip Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ALG11 Gene Congenital disorder of glycosylation, type Ip NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Congenital disorder of glycosylation, type Ip |
Test Details |
ALG11 Gene Congenital disorder of glycosylation, type Ip is a rare genetic disorder that affects the process of adding sugar molecules to proteins and lipids in the body. This disorder is caused by mutations in the ALG11 gene, which is responsible for encoding an enzyme involved in the glycosylation process. NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of genetic variations, including mutations, in a more efficient and comprehensive manner compared to traditional sequencing methods. The ALG11 gene NGS genetic test specifically focuses on sequencing the ALG11 gene to identify any mutations or variations that may be causing the Congenital disorder of glycosylation, type Ip. This test can help diagnose individuals with this disorder, provide information about disease progression and prognosis, and aid in genetic counseling and family planning. It is important to consult with a healthcare professional or genetic counselor to understand the specific implications and limitations of this genetic test, as well as to discuss the potential benefits and risks of undergoing such testing. |